Ganirelix vs Human Chorionic Gonadotropin (HCG)
Fast-acting GnRH antagonist that stops premature ovulation during fertility treatment
A powerful hormone that mimics luteinizing hormone (LH) to stimulate your body's natural testosterone production while keeping your fertility intact—like having your cake and eating it too for men on hormone therapy.
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Quick comparison
Dose range
Ganirelix
250–250 mcg
Human Chorionic Gonadotropin (HCG)
500–1500 IU
Frequency
Ganirelix
Once daily
Human Chorionic Gonadotropin (HCG)
Twice weekly
Administration
Ganirelix
Subcutaneous injection
Human Chorionic Gonadotropin (HCG)
Subcutaneous injection
Cycle length
Ganirelix
Ongoing/indefinite
Human Chorionic Gonadotropin (HCG)
Ongoing/indefinite
Onset speed
Ganirelix
Moderate (1-2 weeks)
Human Chorionic Gonadotropin (HCG)
Moderate (1-2 weeks)
Evidence level
Ganirelix
Strong human trials (Phase 3 or FDA approved)
Human Chorionic Gonadotropin (HCG)
Strong human trials (Phase 3 or FDA approved)
Benefit ratings
Ovulation Control
IVF Success Improvement
Safety & OHSS Prevention
Fertility Preservation
Testicular Health
Hormone Balance
Compound specifications
Ganirelix
Molecular formula
C80H113ClN18O13
Molecular weight
1570.4 g/mol
Half-life
10-12 hours
Bioavailability
~91% (subcutaneous injection)
CAS number
124904-93-4
Human Chorionic Gonadotropin (HCG)
Molecular formula
C1105H1770N318O336S26 (approximate)
Molecular weight
36,700 g/mol (approximately)
Half-life
24-36 hours
Bioavailability
High when injected subcutaneously or intramuscularly
CAS number
9002-61-3
Dosing compared
Ganirelix
Subcutaneous
250 mcg
Once daily during the mid-to-late follicular phase · Continued daily until the day of hCG administration (typically about 5-9 days)
FDA-labeled dose for inhibiting premature LH surges during controlled ovarian stimulation; started after several days of FSH and continued until hCG trigger [4].
Human Chorionic Gonadotropin (HCG)
Subcutaneous
500-1,500 IU
2-3 times per week · Ongoing with TRT
Documented clinical practice for preserving testicular function/fertility in men on testosterone therapy; 1,500-2,000 IU 2-3x/week is used for hypogonadotropic hypogonadism [6]. The popular 500 IU 2-3x/week maintenance figure reflects real-world practice rather than the FDA label. In controlled dosing, 250 IU every other day held intratesticular testosterone within 7% of baseline and 500 IU raised it 26% above baseline during testosterone administration [7]; 500 IU every other day preserved semen parameters with no azoospermia in men on TRT [8].
Intramuscular
500-1,000 IU
3 times weekly for 3 weeks, then 2 times weekly for 3 weeks · 6-week induction course
FDA-labeled regimen for male hypogonadotropic hypogonadism (Pregnyl) [7]. Intramuscular is the only labeled route.
4,000 IU then taper to 2,000 IU
3 times weekly · 4,000 IU for 6-9 months, then 2,000 IU for 3 additional months
Higher-dose FDA-labeled regimen for inducing spermatogenesis/testicular descent (Pregnyl) [7].
Best suited for
Ganirelix
Improving IVF or ICSI success rates
Ganirelix is particularly well-suited for individuals focused on improving ivf or icsi success rates. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Preventing premature ovulation during egg retrieval cycles
Ganirelix is particularly well-suited for individuals focused on preventing premature ovulation during egg retrieval cycles. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Controlling ovarian stimulation in women with unpredictable cycles
Ganirelix is particularly well-suited for individuals focused on controlling ovarian stimulation in women with unpredictable cycles. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Human Chorionic Gonadotropin (HCG)
Fertility Preservation During TRT
If you're on testosterone therapy but want to keep your swimmers swimming, HCG is your best friend. It keeps your testes active and producing sperm even when external testosterone would normally shut that down. Research shows it can maintain or restore spermatogenesis in about 80% of men [3][4][8].
Preventing Testicular Atrophy
Nobody wants their boys to shrink. When you take external testosterone, your brain stops signaling your testes to work—and they get smaller from disuse. HCG mimics the signal (LH) that keeps them active, maintaining their size and function [6][14].
Hypogonadotropic Hypogonadism
If your pituitary gland isn't sending the right signals to your testes (low LH), HCG can step in and do the job. It's been used for decades to treat this condition, helping men achieve normal testosterone levels and fertility [3][6][13].
Post-Cycle Therapy (PCT)
After using anabolic steroids, your natural hormone production is suppressed. HCG can help jumpstart your testes back into action, speeding up the recovery of your natural testosterone production. It's often used as part of a comprehensive PCT protocol [9][15].
Side effects
Ganirelix
Common
- Mild discomfort at treatment site
- Injection site reactions (redness, bruising, swelling)
- Headaches
- Abdominal pain
- Pelvic discomfort
- Nausea
- Fatigue or dizziness
Serious
- Severe allergic reaction
Human Chorionic Gonadotropin (HCG)
Common
- Injection site reactions
- Headache
- Water retention
Uncommon
- Gynecomastia
- Mood changes
- Acne
Serious
- Blood clots
Safety & evidence
Ganirelix
Evidence level
Strong human trials (Phase 3 or FDA approved)
FDA status
FDA approved for this use
Safety overview
Ganirelix carries an excellent safety record from over 10,000 patients in FDA approval trials and 25+ years of clinical fertility practice. The antagonist mechanism avoids the flare effect seen with GnRH agonists, making it safer for women with diminished ovarian reserve. Injection site reactions are the most common issue (20-40% of patients), though typically mild bruising rather than systemic toxicity. The rapid 1-2 hour onset and quick clearance mean side effects resolve quickly if dosing is adjusted.
Contraindications
- Pregnancy or suspected pregnancy
- Breastfeeding
- Known allergies to any medication component
- Ovarian cysts larger than 3cm
Human Chorionic Gonadotropin (HCG)
Evidence level
Strong human trials (Phase 3 or FDA approved)
FDA status
FDA approved for other use
Safety overview
HCG has been used medically for over 80 years with a well-established safety profile. [10] When used appropriately for male hypogonadism or fertility preservation, side effects are generally mild and manageable. The most common issues relate to elevated estrogen from increased testosterone aromatization, which can be managed with aromatase inhibitors if needed. [6][18] Serious side effects are rare when HCG is used under medical supervision.
Contraindications
- Hormone-sensitive cancers (prostate, breast)
- Precocious puberty in children
- Known allergy to HCG or any component
- Pregnancy (in therapeutic male contexts)
- Untreated thyroid or adrenal disorders
Which is right for you?
Choose Ganirelix if...
- Improving IVF or ICSI success rates
- Preventing premature ovulation during egg retrieval cycles
- Controlling ovarian stimulation in women with unpredictable cycles
Choose Human Chorionic Gonadotropin (HCG) if...
- Fertility preservation during TRT
- Maintaining testicular size and function
- Natural testosterone stimulation
- Post-cycle therapy recovery